These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9744512)

  • 21. The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).
    Hürny C; Bernhard J; Bacchi M; van Wegberg B; Tomamichel M; Spek U; Coates A; Castiglione M; Goldhirsch A; Senn HJ
    Support Care Cancer; 1993 Jul; 1(4):200-8. PubMed ID: 8193882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
    Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Subtypes and Prognostic Factors among Premenopausal and Postmenopausal Thai Women with Invasive Breast Cancer: 15 Years Follow-up Data.
    Tubtimhin S; Promthet S; Suwanrungruang K; Supaattagorn P
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3167-3174. PubMed ID: 30486605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study.
    Arraras JI; Manterola A; Asin G; Illarramendi JJ; Cruz Sde L; Ibañez B; Delfrade J; Salgado E; Zarandona U; Cambra K; Vera R; Dominguez MA
    Breast; 2016 Apr; 26():46-53. PubMed ID: 27017241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs.
    Elkin EB; Weinstein MC; Kuntz KM; Bunnell CA; Weeks JC
    Breast Cancer Res Treat; 2005 Sep; 93(1):25-34. PubMed ID: 16184455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
    Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B;
    Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting benefit of endocrine therapy for early breast cancer.
    Regan MM
    Breast; 2015 Nov; 24 Suppl 2(0 2):S129-31. PubMed ID: 26255197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
    Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
    J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial.
    Ganz PA; Kwan L; Stanton AL; Krupnick JL; Rowland JH; Meyerowitz BE; Bower JE; Belin TR
    J Natl Cancer Inst; 2004 Mar; 96(5):376-87. PubMed ID: 14996859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Religiosity and quality of life in breast cancer patients.
    Aukst-Margetić B; Jakovljević M; Ivanec D; Margetić B; Ljubicić D; Samija M
    Coll Antropol; 2009 Dec; 33(4):1265-71. PubMed ID: 20102080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Food habits, socioeconomic status and body mass index among premenopausal and post-menopausal women in Mauritius.
    Bhurosy T; Jeewon R
    J Hum Nutr Diet; 2013 Jul; 26 Suppl 1():114-22. PubMed ID: 23600898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The place of chemotherapy in the treatment of early breast cancer.
    Buzdar A
    Br J Cancer; 1998 Sep; 78 Suppl 4(Suppl 4):16-20. PubMed ID: 9741784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of quality-of-life scores: preliminary results of an analysis of patients with breast cancer.
    Shimozuma K; Sonoo H; Ichihara K; Tanaka K
    Surg Today; 2000; 30(3):255-61. PubMed ID: 10752779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Menopause Symptoms and Attitude Impact Korean Women's Quality of Life After Adjuvant Treatment for Breast Cancer.
    Gang M; Jung MS; Park S; Park Y; Oh K
    Cancer Nurs; 2017; 40(6):E60-E66. PubMed ID: 27922913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy.
    Yeo W; Mo FKF; Pang E; Suen JJS; Koh J; Loong HHF; Yip CCH; Ng RYW; Yip CHW; Tang NLS; Liem GS
    BMC Womens Health; 2017 Jul; 17(1):55. PubMed ID: 28750616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
    Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
    J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.